Five Prime Therapeutics' Series C Round

Five Prime Therapeutics raised a round of funding on February 18, 2005.

Five Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discove…

Articles about Five Prime Therapeutics' Series C Round: